Sethera Therapeutics
Salt Lake City, US · Founded 2024 · Delaware corporation
Sethera Therapeutics develops peptide-based therapeutics using innovative enzyme chemistry research. The company focuses on commercializing novel peptide drugs derived from breakthrough scientific discoveries.
Founders & leadership
YK
Yakov KoganExecutive
VB
Vahe BandarianCSO and President
KE
Karsten EastmanCEO
CT
Cynthia TsaiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 1 round · 2024
▶$1.9MraisedOct 2024 · 21 investors · BiotechnologyRule 506(b)
▶$1.9MraisedOct 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vahe BandarianExecutive Officer, Director
- Karsten EastmanExecutive Officer, Director
- Cynthia TsaiExecutive Officer, Director
- Yakov KoganExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.9M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapAltaThera Pharmaceuticals12 shared keywordsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
RayThera11 shared keywordsRayThera develops small molecule therapies targeting unmet needs in immunology. The company focuses on drug discovery in the biotechnology and immunology space.
ExThera Medical9 shared keywords
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Sethera Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sethera Therapeutics do?
- Sethera Therapeutics develops peptide-based therapeutics using innovative enzyme chemistry research. The company focuses on commercializing novel peptide drugs derived from breakthrough scientific discoveries.
- How much funding has Sethera Therapeutics raised?
- Sethera Therapeutics has disclosed $1.9M raised across 1 round.
- Where is Sethera Therapeutics headquartered?
- Sethera Therapeutics is headquartered in Salt Lake City, US.